F1773262234_EXP2435_PUR7776Final.pdf

PUR 7776 (Eff. 03/2016) Page 1 of 2 60A-1.045, F.A.C.

DESCRIPTION OF INTENDED

SINGLE SOURCE PURCHASE

(PUR 7776)

AGENCY: Department of Health

TITLE: MagnaPure Short description of the commodity or service desired: Nucleic Extraction Instruments

CONTACT

Name: Sonja German Address: 4052 Bald Cypress Way, Tallahassee, FL 32399 Telephone: (850) 245-4199 Email: sonja.german@flhealth.gov

Internal tracking number, if any: EXP2435

Date posted: 3/4/22 @ 4:45pm Last day for receipt of information: 3/25/22 @ 4:45pm

This description of commodities or contractual services intended for purchase from a single source is posted in accordance with sections 120.57(3) and 287.057(3), Florida Statutes and will remain posted for a period of at least 15 business days.

Commodity or Contractual Service Required (commodity or United National Standard Products and Services Code (UNSPSC), manufacturer, model, and description, as appropriate):

41113000 Chemical evaluation instruments and supplies

Quantity or Term (as appropriate):

1 year

Requestor (division, bureau, office, individual, as appropriate):

Division of Disease Control and Health Protection, Bureau of Public Health Laboratories (BPHL)

Performance and/or Design Requirements (e.g. intended use, function or application, compatibility, requirements;

reference to policy, rule, statute or other act of the Legislature, etc., as appropriate):

The Florida Department of Health, Bureau of Public Health Laboratories needs to purchase nucleic acid extraction instruments to replace the existing Roche MagNA Pure LC 2.0 and MagNA Pure Compact instruments. The instrument must be validated and approved by the Centers for Disease Control and Prevention for public health emergency preparedness activities, including pandemic influenza and Laboratory Response Network methods for detecting bioterrorism threat agents and emerging infectious diseases. BPHL needs an instrument that will extract up to 24 samples at a time within a short turnaround time to provide results as quickly as possible. The Public Health Laboratory Response Network performance measures state that LRN laboratories must have quick turnaround time for testing samples related to public health. In accordance with Chapter 60A-1.045, Florida Administrative Code, the Department of Health requests authorization to purchase 3 MagNa Pure 24 laboratory instruments, as a single source from Roche Diagnostics Corporation.

Intended Single Source:

Roche Diagnostics Corporation mailto:sonja.german@flhealth.gov

PUR 7776 (Eff. 03/2016) Page 2 of 2 60A-1.045, F.A.C.

Estimated Dollar Amount:

$150,000.00

Justification for single source acquisition (what is necessary and unique about the product, service or source; steps taken to confirm unavailability of competition, as appropriate):

• Roche Diagnostics Corporation is the exclusive manufacturer and distributor of the MagNa Pure 24 instrument. The MagNa Pure 24 is the only instrument that can extract up to 24 samples within a short turnaround time (4–6 hours). It is in the best interest of the state to purchase these instruments for quick turnaround results for the safety of the public.

Approved By (names & titles, as appropriate, e.g., requestor, requestor management, information systems, budget, purchasing):

Samantha Washington, Chief, Bureau of General Services

Prospective vendors are requested to provide information regarding their ability to supply the commodities or contractual services described. If it is determined in writing by the agency, after reviewing any information received from prospective vendors, that the commodities or contractual services are available only from a single source, the agency shall: provide notice of its intended decision to enter a single-source purchase contract in the manner specified in s.120.57(3), FS.